This paper analyses the integrated circuit and pharmaceutical GVCs to determine the scope of technical upgrading and value capture achieved by Chinese and Indian contract R&D firms within these GVCs. There are three main findings. First, the two sectors differ significantly in terms of the...

This essay, based on internal capital market (thereinafter as “ICM”) research of Harbin Pharmaceutical Group Co., Ltd. (thereinafter as “HPGC”), summarizes an effective mode for ICM operation of state-owned enterprises and proposes a basic framework for ICM operating of Chinese...

Calls for reform of the Chinese healthcare system are voiced at the highest levels of government, but this article argues that reform cannot succeed unless policymakers confront the incentives for corruption built into the institutional structure of the healthcare system. Focusing on the markets...